Germline copy number variation and ovarian cancer survival

Brooke L. Fridley, Prabhakar Chalise, Ya Yu Tsai, Zhifu D Sun, Robert A. Vierkant, Melissa C. Larson, Julie M Cunningham, Edwin S. Iversen, David Fenstermacher, Jill Barnholtz-Sloan, Yan Asmann, Harvey A. Risch, Joellen M. Schildkraut, Catherine M. Phelan, Rebecca Sutphen, Thomas A. Sellers, Ellen L Goode

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Copy number variants (CNVs) have been implicated in many complex diseases.We examined whether inherited CNVs were associated with overall survival among women with invasive epithelial ovarian cancer. Germline DNA from 1,056 cases (494 deceased, average of 3.7 years follow-up) was interrogated with the Illumina 610 quad genome-wide array containing, after quality control exclusions, 581,903 single nucleotide polymorphisms (SNPs) and 17,917 CNV probes. Comprehensive analysis capitalized upon the strengths of three complementary approaches to CNV classification. First, to identify small CNVs, single markers were evaluated and, where associated with survival, consecutive markers were combined. Two chromosomal regions were associated with survival using this approach (14q31.3 rs2274736 p=1.59×10-6, p=0.001; 22q13.31 rs2285164 p =4.01×10-5, p=0.009), but were not significant after multiple testing correction. Second, to identify large CNVs, genome-wide segmentation was conducted to characterize chromosomal gains and losses, and association with survival was evaluated by segment. Four regions were associated with survival (1q21.3 loss p=0.005, 5p14.1 loss p=0.004, 9p23 loss p=0.002, and 15q22.31 gain p=0.002); however, again, after correcting for multiple testing, no regions were statistically significant, and none were in common with the single marker approach. Finally, to evaluate associations with general amounts of copy number changes across the genome, we estimated CNV burden based on genome-wide numbers of gains and losses; no associations with survival were observed (p >0.40). Although CNVs that were not well-covered by the Illumina 610 quad array merit investigation, these data suggest no association between inherited CNVs and survival after ovarian cancer.

Original languageEnglish (US)
Article numberArticle 142
JournalFrontiers in Genetics
Volume3
Issue numberAUG
DOIs
StatePublished - 2012

Fingerprint

Ovarian Neoplasms
Survival
Genome
Quality Control
Single Nucleotide Polymorphism
DNA
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination

Keywords

  • Association testing
  • Copy number variation
  • Genotyping array
  • Ovarian cancer
  • Overall survival

ASJC Scopus subject areas

  • Genetics
  • Molecular Medicine
  • Genetics(clinical)

Cite this

Fridley, B. L., Chalise, P., Tsai, Y. Y., Sun, Z. D., Vierkant, R. A., Larson, M. C., ... Goode, E. L. (2012). Germline copy number variation and ovarian cancer survival. Frontiers in Genetics, 3(AUG), [Article 142]. https://doi.org/10.3389/fgene.2012.00142

Germline copy number variation and ovarian cancer survival. / Fridley, Brooke L.; Chalise, Prabhakar; Tsai, Ya Yu; Sun, Zhifu D; Vierkant, Robert A.; Larson, Melissa C.; Cunningham, Julie M; Iversen, Edwin S.; Fenstermacher, David; Barnholtz-Sloan, Jill; Asmann, Yan; Risch, Harvey A.; Schildkraut, Joellen M.; Phelan, Catherine M.; Sutphen, Rebecca; Sellers, Thomas A.; Goode, Ellen L.

In: Frontiers in Genetics, Vol. 3, No. AUG, Article 142, 2012.

Research output: Contribution to journalArticle

Fridley, BL, Chalise, P, Tsai, YY, Sun, ZD, Vierkant, RA, Larson, MC, Cunningham, JM, Iversen, ES, Fenstermacher, D, Barnholtz-Sloan, J, Asmann, Y, Risch, HA, Schildkraut, JM, Phelan, CM, Sutphen, R, Sellers, TA & Goode, EL 2012, 'Germline copy number variation and ovarian cancer survival', Frontiers in Genetics, vol. 3, no. AUG, Article 142. https://doi.org/10.3389/fgene.2012.00142
Fridley BL, Chalise P, Tsai YY, Sun ZD, Vierkant RA, Larson MC et al. Germline copy number variation and ovarian cancer survival. Frontiers in Genetics. 2012;3(AUG). Article 142. https://doi.org/10.3389/fgene.2012.00142
Fridley, Brooke L. ; Chalise, Prabhakar ; Tsai, Ya Yu ; Sun, Zhifu D ; Vierkant, Robert A. ; Larson, Melissa C. ; Cunningham, Julie M ; Iversen, Edwin S. ; Fenstermacher, David ; Barnholtz-Sloan, Jill ; Asmann, Yan ; Risch, Harvey A. ; Schildkraut, Joellen M. ; Phelan, Catherine M. ; Sutphen, Rebecca ; Sellers, Thomas A. ; Goode, Ellen L. / Germline copy number variation and ovarian cancer survival. In: Frontiers in Genetics. 2012 ; Vol. 3, No. AUG.
@article{e890c1f284bd40e2aea8d8fea16e2fca,
title = "Germline copy number variation and ovarian cancer survival",
abstract = "Copy number variants (CNVs) have been implicated in many complex diseases.We examined whether inherited CNVs were associated with overall survival among women with invasive epithelial ovarian cancer. Germline DNA from 1,056 cases (494 deceased, average of 3.7 years follow-up) was interrogated with the Illumina 610 quad genome-wide array containing, after quality control exclusions, 581,903 single nucleotide polymorphisms (SNPs) and 17,917 CNV probes. Comprehensive analysis capitalized upon the strengths of three complementary approaches to CNV classification. First, to identify small CNVs, single markers were evaluated and, where associated with survival, consecutive markers were combined. Two chromosomal regions were associated with survival using this approach (14q31.3 rs2274736 p=1.59×10-6, p=0.001; 22q13.31 rs2285164 p =4.01×10-5, p=0.009), but were not significant after multiple testing correction. Second, to identify large CNVs, genome-wide segmentation was conducted to characterize chromosomal gains and losses, and association with survival was evaluated by segment. Four regions were associated with survival (1q21.3 loss p=0.005, 5p14.1 loss p=0.004, 9p23 loss p=0.002, and 15q22.31 gain p=0.002); however, again, after correcting for multiple testing, no regions were statistically significant, and none were in common with the single marker approach. Finally, to evaluate associations with general amounts of copy number changes across the genome, we estimated CNV burden based on genome-wide numbers of gains and losses; no associations with survival were observed (p >0.40). Although CNVs that were not well-covered by the Illumina 610 quad array merit investigation, these data suggest no association between inherited CNVs and survival after ovarian cancer.",
keywords = "Association testing, Copy number variation, Genotyping array, Ovarian cancer, Overall survival",
author = "Fridley, {Brooke L.} and Prabhakar Chalise and Tsai, {Ya Yu} and Sun, {Zhifu D} and Vierkant, {Robert A.} and Larson, {Melissa C.} and Cunningham, {Julie M} and Iversen, {Edwin S.} and David Fenstermacher and Jill Barnholtz-Sloan and Yan Asmann and Risch, {Harvey A.} and Schildkraut, {Joellen M.} and Phelan, {Catherine M.} and Rebecca Sutphen and Sellers, {Thomas A.} and Goode, {Ellen L}",
year = "2012",
doi = "10.3389/fgene.2012.00142",
language = "English (US)",
volume = "3",
journal = "Frontiers in Genetics",
issn = "1664-8021",
publisher = "Frontiers Media S. A.",
number = "AUG",

}

TY - JOUR

T1 - Germline copy number variation and ovarian cancer survival

AU - Fridley, Brooke L.

AU - Chalise, Prabhakar

AU - Tsai, Ya Yu

AU - Sun, Zhifu D

AU - Vierkant, Robert A.

AU - Larson, Melissa C.

AU - Cunningham, Julie M

AU - Iversen, Edwin S.

AU - Fenstermacher, David

AU - Barnholtz-Sloan, Jill

AU - Asmann, Yan

AU - Risch, Harvey A.

AU - Schildkraut, Joellen M.

AU - Phelan, Catherine M.

AU - Sutphen, Rebecca

AU - Sellers, Thomas A.

AU - Goode, Ellen L

PY - 2012

Y1 - 2012

N2 - Copy number variants (CNVs) have been implicated in many complex diseases.We examined whether inherited CNVs were associated with overall survival among women with invasive epithelial ovarian cancer. Germline DNA from 1,056 cases (494 deceased, average of 3.7 years follow-up) was interrogated with the Illumina 610 quad genome-wide array containing, after quality control exclusions, 581,903 single nucleotide polymorphisms (SNPs) and 17,917 CNV probes. Comprehensive analysis capitalized upon the strengths of three complementary approaches to CNV classification. First, to identify small CNVs, single markers were evaluated and, where associated with survival, consecutive markers were combined. Two chromosomal regions were associated with survival using this approach (14q31.3 rs2274736 p=1.59×10-6, p=0.001; 22q13.31 rs2285164 p =4.01×10-5, p=0.009), but were not significant after multiple testing correction. Second, to identify large CNVs, genome-wide segmentation was conducted to characterize chromosomal gains and losses, and association with survival was evaluated by segment. Four regions were associated with survival (1q21.3 loss p=0.005, 5p14.1 loss p=0.004, 9p23 loss p=0.002, and 15q22.31 gain p=0.002); however, again, after correcting for multiple testing, no regions were statistically significant, and none were in common with the single marker approach. Finally, to evaluate associations with general amounts of copy number changes across the genome, we estimated CNV burden based on genome-wide numbers of gains and losses; no associations with survival were observed (p >0.40). Although CNVs that were not well-covered by the Illumina 610 quad array merit investigation, these data suggest no association between inherited CNVs and survival after ovarian cancer.

AB - Copy number variants (CNVs) have been implicated in many complex diseases.We examined whether inherited CNVs were associated with overall survival among women with invasive epithelial ovarian cancer. Germline DNA from 1,056 cases (494 deceased, average of 3.7 years follow-up) was interrogated with the Illumina 610 quad genome-wide array containing, after quality control exclusions, 581,903 single nucleotide polymorphisms (SNPs) and 17,917 CNV probes. Comprehensive analysis capitalized upon the strengths of three complementary approaches to CNV classification. First, to identify small CNVs, single markers were evaluated and, where associated with survival, consecutive markers were combined. Two chromosomal regions were associated with survival using this approach (14q31.3 rs2274736 p=1.59×10-6, p=0.001; 22q13.31 rs2285164 p =4.01×10-5, p=0.009), but were not significant after multiple testing correction. Second, to identify large CNVs, genome-wide segmentation was conducted to characterize chromosomal gains and losses, and association with survival was evaluated by segment. Four regions were associated with survival (1q21.3 loss p=0.005, 5p14.1 loss p=0.004, 9p23 loss p=0.002, and 15q22.31 gain p=0.002); however, again, after correcting for multiple testing, no regions were statistically significant, and none were in common with the single marker approach. Finally, to evaluate associations with general amounts of copy number changes across the genome, we estimated CNV burden based on genome-wide numbers of gains and losses; no associations with survival were observed (p >0.40). Although CNVs that were not well-covered by the Illumina 610 quad array merit investigation, these data suggest no association between inherited CNVs and survival after ovarian cancer.

KW - Association testing

KW - Copy number variation

KW - Genotyping array

KW - Ovarian cancer

KW - Overall survival

UR - http://www.scopus.com/inward/record.url?scp=84876144579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876144579&partnerID=8YFLogxK

U2 - 10.3389/fgene.2012.00142

DO - 10.3389/fgene.2012.00142

M3 - Article

C2 - 22891074

AN - SCOPUS:84876144579

VL - 3

JO - Frontiers in Genetics

JF - Frontiers in Genetics

SN - 1664-8021

IS - AUG

M1 - Article 142

ER -